vs
雅培（CLB）与MARCUS CORP（MCS）财务数据对比。点击上方公司名可切换其他公司
MARCUS CORP的季度营收约是雅培的1.6倍（$193.5M vs $121.8M），MARCUS CORP同比增速更快（2.8% vs -1.4%），MARCUS CORP自由现金流更多（$26.4M vs $517.0K），过去两年MARCUS CORP的营收复合增速更高（18.2% vs -3.4%）
雅培是一家总部位于美国伊利诺伊州阿伯特公园的跨国医疗保健企业，在全球医疗健康领域开展业务，主营诊断产品、营养健康产品、医疗器械，同时在美国境外销售医药产品，是全球知名的医疗健康提供商。
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
CLB vs MCS — 直观对比
营收规模更大
MCS
是对方的1.6倍
$121.8M
营收增速更快
MCS
高出4.2%
-1.4%
自由现金流更多
MCS
多$25.9M
$517.0K
两年增速更快
MCS
近两年复合增速
-3.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $121.8M | $193.5M |
| 净利润 | $5.1M | — |
| 毛利率 | — | — |
| 营业利润率 | 1.5% | 0.9% |
| 净利率 | 4.2% | — |
| 营收同比 | -1.4% | 2.8% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLBMCS
| Q1 26 | $121.8M | — | ||
| Q4 25 | $138.3M | $193.5M | ||
| Q3 25 | $134.5M | $210.2M | ||
| Q2 25 | $130.2M | $206.0M | ||
| Q1 25 | $123.6M | $148.8M | ||
| Q4 24 | $129.2M | $188.3M | ||
| Q3 24 | $134.4M | $232.7M | ||
| Q2 24 | $130.6M | $176.0M |
净利润CLBMCS
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.9M | — | ||
| Q3 25 | $14.2M | $16.2M | ||
| Q2 25 | $10.6M | $7.3M | ||
| Q1 25 | $-154.0K | $-16.8M | ||
| Q4 24 | $7.4M | $986.0K | ||
| Q3 24 | $11.7M | $23.3M | ||
| Q2 24 | $9.0M | $-20.2M |
毛利率CLBMCS
| Q1 26 | — | — | ||
| Q4 25 | 20.8% | — | ||
| Q3 25 | 22.0% | — | ||
| Q2 25 | 20.3% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 21.2% | — |
营业利润率CLBMCS
| Q1 26 | 1.5% | — | ||
| Q4 25 | 11.5% | 0.9% | ||
| Q3 25 | 15.6% | 10.8% | ||
| Q2 25 | 11.7% | 6.3% | ||
| Q1 25 | 3.6% | -13.7% | ||
| Q4 24 | 11.0% | -1.2% | ||
| Q3 24 | 14.7% | 14.1% | ||
| Q2 24 | 12.3% | 1.3% |
净利率CLBMCS
| Q1 26 | 4.2% | — | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 10.6% | 7.7% | ||
| Q2 25 | 8.2% | 3.6% | ||
| Q1 25 | -0.1% | -11.3% | ||
| Q4 24 | 5.7% | 0.5% | ||
| Q3 24 | 8.7% | 10.0% | ||
| Q2 24 | 6.9% | -11.5% |
每股收益（稀释后）CLBMCS
| Q1 26 | $0.11 | — | ||
| Q4 25 | $0.11 | — | ||
| Q3 25 | $0.30 | — | ||
| Q2 25 | $0.22 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $0.15 | — | ||
| Q3 24 | $0.25 | — | ||
| Q2 24 | $0.19 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.8M | $23.4M |
| 总债务越低越好 | — | $159.0M |
| 股东权益账面价值 | $275.1M | $457.4M |
| 总资产 | $587.7M | $1.0B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资CLBMCS
| Q1 26 | $22.8M | — | ||
| Q4 25 | $22.7M | $23.4M | ||
| Q3 25 | $25.6M | $7.4M | ||
| Q2 25 | $31.2M | $14.9M | ||
| Q1 25 | $22.1M | $11.9M | ||
| Q4 24 | $19.2M | $40.8M | ||
| Q3 24 | $21.5M | $28.4M | ||
| Q2 24 | $17.7M | $32.8M |
总债务CLBMCS
| Q1 26 | — | — | ||
| Q4 25 | $110.3M | $159.0M | ||
| Q3 25 | $114.1M | $162.0M | ||
| Q2 25 | $124.6M | $179.9M | ||
| Q1 25 | $124.4M | $198.9M | ||
| Q4 24 | $126.1M | $159.1M | ||
| Q3 24 | $139.9M | $173.1M | ||
| Q2 24 | $147.6M | $175.7M |
股东权益CLBMCS
| Q1 26 | $275.1M | — | ||
| Q4 25 | $266.0M | $457.4M | ||
| Q3 25 | $271.3M | $454.3M | ||
| Q2 25 | $261.3M | $448.4M | ||
| Q1 25 | $253.4M | $441.8M | ||
| Q4 24 | $246.6M | $464.9M | ||
| Q3 24 | $250.7M | $462.3M | ||
| Q2 24 | $240.3M | $449.4M |
总资产CLBMCS
| Q1 26 | $587.7M | — | ||
| Q4 25 | $584.0M | $1.0B | ||
| Q3 25 | $591.4M | $1.0B | ||
| Q2 25 | $602.1M | $1.0B | ||
| Q1 25 | $591.5M | $1.0B | ||
| Q4 24 | $585.1M | $1.0B | ||
| Q3 24 | $600.5M | $1.0B | ||
| Q2 24 | $597.8M | $1.1B |
负债/权益比CLBMCS
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | 0.35× | ||
| Q3 25 | 0.42× | 0.36× | ||
| Q2 25 | 0.48× | 0.40× | ||
| Q1 25 | 0.49× | 0.45× | ||
| Q4 24 | 0.51× | 0.34× | ||
| Q3 24 | 0.56× | 0.37× | ||
| Q2 24 | 0.61× | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $517.0K | $26.4M |
| 自由现金流率自由现金流/营收 | 0.4% | 13.6% |
| 资本支出强度资本支出/营收 | — | 11.6% |
| 现金转化率经营现金流/净利润 | 0.77× | — |
| 过去12个月自由现金流最近4个季度 | $22.5M | $989.0K |
8季度趋势，按日历期对齐
经营现金流CLBMCS
| Q1 26 | $4.0M | — | ||
| Q4 25 | $7.9M | $48.8M | ||
| Q3 25 | $8.5M | $39.1M | ||
| Q2 25 | $13.9M | $31.6M | ||
| Q1 25 | $6.7M | $-35.3M | ||
| Q4 24 | $20.6M | $52.6M | ||
| Q3 24 | $13.1M | $30.5M | ||
| Q2 24 | $17.1M | $36.0M |
自由现金流CLBMCS
| Q1 26 | $517.0K | — | ||
| Q4 25 | $5.0M | $26.4M | ||
| Q3 25 | $6.5M | $18.2M | ||
| Q2 25 | $10.4M | $14.7M | ||
| Q1 25 | $3.9M | $-58.3M | ||
| Q4 24 | $17.4M | $27.1M | ||
| Q3 24 | $10.4M | $12.0M | ||
| Q2 24 | $14.3M | $16.1M |
自由现金流率CLBMCS
| Q1 26 | 0.4% | — | ||
| Q4 25 | 3.6% | 13.6% | ||
| Q3 25 | 4.8% | 8.7% | ||
| Q2 25 | 8.0% | 7.1% | ||
| Q1 25 | 3.1% | -39.2% | ||
| Q4 24 | 13.4% | 14.4% | ||
| Q3 24 | 7.7% | 5.2% | ||
| Q2 24 | 10.9% | 9.2% |
资本支出强度CLBMCS
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 11.6% | ||
| Q3 25 | 1.5% | 9.9% | ||
| Q2 25 | 2.7% | 8.2% | ||
| Q1 25 | 2.3% | 15.5% | ||
| Q4 24 | 2.5% | 13.5% | ||
| Q3 24 | 2.0% | 7.9% | ||
| Q2 24 | 2.2% | 11.3% |
现金转化率CLBMCS
| Q1 26 | 0.77× | — | ||
| Q4 25 | 1.61× | — | ||
| Q3 25 | 0.60× | 2.41× | ||
| Q2 25 | 1.31× | 4.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.78× | 53.31× | ||
| Q3 24 | 1.12× | 1.31× | ||
| Q2 24 | 1.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLB
暂无分部数据
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
